Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) PT at $90.79

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned a consensus recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $88.6429.

A number of research analysts recently issued reports on COO shares. The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research report on Wednesday. Citigroup reiterated a “neutral” rating and set a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Needham & Company LLC boosted their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Root Financial Partners LLC raised its holdings in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the last quarter. SJS Investment Consulting Inc. raised its holdings in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares during the last quarter. Bell Investment Advisors Inc raised its holdings in Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in Cooper Companies during the second quarter worth $36,000. Finally, True Wealth Design LLC raised its holdings in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.4%

NASDAQ:COO opened at $61.04 on Friday. The firm’s fifty day moving average is $66.16 and its 200-day moving average is $74.96. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. Cooper Companies has a 52 week low of $58.89 and a 52 week high of $89.83. The firm has a market cap of $11.91 billion, a P/E ratio of 30.22, a P/E/G ratio of 1.57 and a beta of 0.89.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the prior year, the firm posted $0.92 EPS. The company’s quarterly revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that Cooper Companies will post 4.62 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.